USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: IOGENETICS, LLC
City: MADISON
State: WI
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,090,910.00 2
SBIR Phase II $6,597,525.00 2

Award List:

Antibody-Biocide Fusions to Control Cryptosporidium

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael Imboden
Award Amount: $1,001,223.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this research is develop therapeutic products for Cryptosporidium parvum which can be made at a scale and cost which are feasible for delivery to large populations of patients or individuals at risk, as may be necessary in countering bioterrorism, or… More

Retrovectors for Intron-Enhanced Protein Expression

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael Imboden
Award Amount: $89,687.00
Abstract:
DESCRIPTION (provided by applicant): Retrovectors are widely used for gene transfer in gene therapy, tissue culture and transgenic animals for research or commercial applications.. A long recognized limitation of current retrovectors is that introns are spliced out as retrovector particles are… More

Antibody-Biocide Fusions to Control Cryptosporidium

Award Year / Program / Phase: 2006 / SBIR / Phase II
Agency: HHS
Principal Investigator: Michael Imboden
Award Amount: $3,600,017.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this research is develop therapeutic products for Cryptosporidium parvum which can be made at a scale and cost which are feasible for delivery to large populations of patients or individuals at risk, as may be necessary in countering bioterrorism, or… More

Antibody-Biocide Fusions to Control Cryptosporidium

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Michael Imboden
Award Amount: $2,997,508.00
Abstract:
DESCRIPTION (provided by applicant): Cryptosporidiosis is a leading cause of diarrheal disease worldwide and is a category B biothreat agent. Two major species, Cryptosporidium hominis and Cryptosporidium parvum are responsible for over ninety percent of c ases in man. C. parvum is zoonotic, with a… More